TGF-beta and tumors--an ill-fated alliance

Curr Opin Immunol. 2008 Apr;20(2):234-40. doi: 10.1016/j.coi.2008.04.003. Epub 2008 May 15.

Abstract

Mechanisms of host defense can form an unwitting alliance with tumor cells to promote tumor progression, invasion, and dissemination to distant sites. By secreting TGF-beta, an immunoregulatory molecule designated for both promoting inflammation and dampening immune responses, the tumor tricks the host into supporting its expansion and survival. TGF-beta not only recruits leukocytes to secrete chemokines, growth factors, cytokines, and proteases in support of a tumor-friendly niche but also in a context-specific manner, incapacitates the emergent immune response. As a profound immunosuppressant, TGF-beta, both directly and through the generation of regulatory T cells, blunts immune surveillance, favoring tumor escape. Collectively, the ability of the tumor to hijack these host defense pathways can tip the balance in favor of the tumor.

Publication types

  • Research Support, N.I.H., Intramural
  • Review

MeSH terms

  • Animals
  • Carcinoma, Squamous Cell / immunology
  • Head and Neck Neoplasms / immunology
  • Humans
  • Mice
  • Neoplasms / immunology*
  • T-Lymphocytes, Regulatory / immunology
  • Transforming Growth Factor beta / physiology*
  • Tumor Escape*

Substances

  • Transforming Growth Factor beta